Literature DB >> 15100096

Androgens augment proximal tubule transport.

Albert Quan1, Sumana Chakravarty, Jian-Kang Chen, Jian-Chun Chen, Samer Loleh, Neel Saini, Ray C Harris, Jorge Capdevila, Raymond Quigley.   

Abstract

The proximal tubule contains an autonomous renin-angiotensin system that regulates transport independently of circulating angiotensin II. Androgens are known to increase expression of angiotensinogen, but the effect of androgens on proximal tubule transport is unknown. In this in vivo microperfusion study, we examined the effect of androgens on proximal tubule transport. The volume reabsorptive rate in Sprague-Dawley rats given dihydrotestosterone (DHT) injections was significantly higher than in control rats given vehicle injections (4.57 +/- 0.31 vs. 3.31 +/- 0.23 nl x min(-1) x mm(-1), P < 0.01). Luminally perfusing with either enalaprilat (10(-4) M) to inhibit production of angiotensin II or losartan (10(-8) M) to block the angiotensin receptor decreased the proximal tubule volume reabsorptive rate in DHT-treated rats to a significantly greater degree than in control vehicle-injected rats. The renal expression of angiotensinogen was shown to be higher in the DHT-treated animals, using Northern blot analysis. The expression of angiotensin receptors, determined by specific binding of angiotensin II, was not different in the two groups of animals. Brush-border membrane protein abundance of the Na/H exchanger, a membrane transport protein under angiotensin II regulation, was also higher in DHT-treated rats vs. control rats. Rats that received DHT had higher blood pressures than the control rats but had no change in their glomerular filtration rate. In addition, serum angiotensin II levels were lower in DHT-treated vs. control rats. These results suggest that androgens may directly upregulate the proximal tubule renin-angiotensin system, increase the volume reabsorptive rate, and thereby increase extracellular volume and blood pressure and secondarily decrease serum angiotensin II levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100096     DOI: 10.1152/ajprenal.00188.2003

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  47 in total

1.  Sexual Dimorphic Pattern of Renal Transporters and Electrolyte Homeostasis.

Authors:  Luciana C Veiras; Adriana C C Girardi; Joshua Curry; Lei Pei; Donna L Ralph; An Tran; Regiane C Castelo-Branco; Nuria Pastor-Soler; Cristina T Arranz; Alan S L Yu; Alicia A McDonough
Journal:  J Am Soc Nephrol       Date:  2017-08-03       Impact factor: 10.121

2.  Testosterone supplementation in male obese Zucker rats reduces body weight and improves insulin sensitivity but increases blood pressure.

Authors:  Deborah D Davis; Arnaldo Lopez Ruiz; Licy L Yanes; Radu Iliescu; Kuichang Yuan; Mohadetheh Moulana; Lorraine C Racusen; Jane F Reckelhoff
Journal:  Hypertension       Date:  2012-01-23       Impact factor: 10.190

3.  Increased renal proximal convoluted tubule transport contributes to hypertension in Cyp4a14 knockout mice.

Authors:  Raymond Quigley; Sumana Chakravarty; Xueying Zhao; John D Imig; Jorge H Capdevila
Journal:  Nephron Physiol       Date:  2009-08-28

4.  Wasting away: How to treat cachexia and muscle wasting in chronic disease?

Authors:  Stephan von Haehling
Journal:  Br J Clin Pharmacol       Date:  2017-08-24       Impact factor: 4.335

Review 5.  Testosterone therapy and prostate cancer--safety concerns are well founded.

Authors:  Laurence Klotz
Journal:  Nat Rev Urol       Date:  2015-01       Impact factor: 14.432

6.  Overexpression of mouse angiotensinogen in renal proximal tubule causes salt-sensitive hypertension in mice.

Authors:  Jian Ying; Deborah Stuart; Elaine Hillas; Barbu R Gociman; Nirupama Ramkumar; Jean-Marc Lalouel; Donald E Kohan
Journal:  Am J Hypertens       Date:  2012-03-01       Impact factor: 2.689

7.  6β-Hydroxytestosterone, a Cytochrome P450 1B1-Testosterone-Metabolite, Mediates Angiotensin II-Induced Renal Dysfunction in Male Mice.

Authors:  Ajeeth K Pingili; Shyamala Thirunavukkarasu; Mehmet Kara; David D Brand; Akemi Katsurada; Dewan S A Majid; L Gabriel Navar; Frank J Gonzalez; Kafait U Malik
Journal:  Hypertension       Date:  2016-02-29       Impact factor: 10.190

8.  Adverse events associated with testosterone administration.

Authors:  Shehzad Basaria; Andrea D Coviello; Thomas G Travison; Thomas W Storer; Wildon R Farwell; Alan M Jette; Richard Eder; Sharon Tennstedt; Jagadish Ulloor; Anqi Zhang; Karen Choong; Kishore M Lakshman; Norman A Mazer; Renee Miciek; Joanne Krasnoff; Ayan Elmi; Philip E Knapp; Brad Brooks; Erica Appleman; Sheetal Aggarwal; Geeta Bhasin; Leif Hede-Brierley; Ashmeet Bhatia; Lauren Collins; Nathan LeBrasseur; Louis D Fiore; Shalender Bhasin
Journal:  N Engl J Med       Date:  2010-06-30       Impact factor: 91.245

9.  Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy.

Authors:  Jacques Baillargeon; Randall J Urban; Yong-Fang Kuo; Kenneth J Ottenbacher; Mukaila A Raji; Fei Du; Yu-Li Lin; James S Goodwin
Journal:  Ann Pharmacother       Date:  2014-07-02       Impact factor: 3.154

10.  Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers.

Authors:  Sonali S Patel; Uyen Truong; Martina King; Annie Ferland; Kerrie L Moreau; Jennifer Dorosz; John E Hokanson; Hong Wang; Gregory L Kinney; David M Maahs; Robert H Eckel; Kristen J Nadeau; Melanie Cree-Green
Journal:  Vasc Med       Date:  2017-01-17       Impact factor: 3.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.